Jun 10, 2020   SOURCE: PR NewsWire

Outlook on the Global Anti-rheumatics Industry to 2025 - Key Drivers, Restraints and Opportunities

DUBLIN, June 10, 2020 /PRNewswire/ -- The "Anti-rheumatics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The report on the global anti-rheumatics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global anti-rheumatics market to grow with a CAGR of 9.5% over the forecast period from 2019-2025. The study on anti-rheumatics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on anti-rheumatics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global anti-rheumatics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global anti-rheumatics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

    --  Rising prevalence of rheumatoid arthritis, increase in geriatric
        population and increasing novel therapeutics
    --  Rising healthcare awareness, increase in disposable income and
        availability of various treatments for inflammatory arthritides

2) Restraints

    --  Many side effects associated with therapy and medication

3) Opportunities

    --  Technological advancement for new drug development and favorable
        government support

Segment Covered
The global anti-rheumatics market is segmented on the basis of drug class, type, end user, and distribution channel.

The Global Anti-rheumatics Market by Drug Class

    --  Disease Modifying Anti-rheumatics Drugs (DMARD's)
    --  Nonsteroidal Anti-inflammatory Drugs (NSAID's)
    --  Corticosteroids
    --  Uric Acid Drugs
    --  Others

The Global Anti-rheumatics Market by Type

    --  Prescription-based Drugs
    --  Over-the-Counter Drugs

The Global Anti-rheumatics Market by End User

    --  Hospitals & Clinics
    --  Ambulatory Surgical Centers
    --  Healthcare Specialty Process

The Global Anti-rheumatics Market by Distribution Channel

    --  Retail Pharmacies
    --  Online Pharmacies
    --  Hospital Pharmacies

What does this report deliver?

    1. Comprehensive analysis of the global as well as regional markets of the
       anti-rheumatics market.
    2. Complete coverage of all the segments in the anti-rheumatics market to
       analyze the trends, developments in the global market and forecast of
       market size up to 2025.
    3. Comprehensive analysis of the companies operating in the global
       anti-rheumatics market. The company profile includes analysis of product
       portfolio, revenue, SWOT analysis and latest developments of the company.
    4. Growth Matrix presents an analysis of the product segments and
       geographies that market players should focus to invest, consolidate,
       expand and/or diversify.

Key Topics Covered:

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Anti-rheumatics Market Highlights
2.2. Anti-rheumatics Market Projection
2.3. Anti-rheumatics Market Regional Highlights

3. Global Anti-rheumatics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Type
3.4.3. Growth Matrix Analysis by End User
3.4.4. Growth Matrix Analysis by Distribution Channel
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Anti-rheumatics Market

4. Anti-rheumatics Market Macro Indicator Analysis

5. Global Anti-rheumatics Market by Drug Class
5.1. Disease Modifying Anti-rheumatics Drugs (DMARD's)
5.2. Nonsteroidal Anti-inflammatory Drugs (NSAID's)
5.3. Corticosteroids
5.4. Uric Acid Drugs
5.5. Others

6. Global Anti-rheumatics Market by Type
6.1. Prescription-based Drugs
6.2. Over-the-Counter Drugs

7. Global Anti-rheumatics Market by End User
7.1. Hospitals & Clinics
7.2. Ambulatory Surgical Centers
7.3. Healthcare Specialty Process

8. Global Anti-rheumatics Market by Distribution Channel
8.1. Retail Pharmacies
8.2. Online Pharmacies
8.3. Hospital Pharmacies

9. Global Anti-rheumatics Market by Region 2019-2025
9.1. North America
9.1.1. North America Anti-rheumatics Market by Drug Class
9.1.2. North America Anti-rheumatics Market by Type
9.1.3. North America Anti-rheumatics Market by End User
9.1.4. North America Anti-rheumatics Market by Distribution Channel
9.1.5. North America Anti-rheumatics Market by Country
9.2. Europe
9.2.1. Europe Anti-rheumatics Market by Drug Class
9.2.2. Europe Anti-rheumatics Market by Type
9.2.3. Europe Anti-rheumatics Market by End User
9.2.4. Europe Anti-rheumatics Market by Distribution Channel
9.2.5. Europe Anti-rheumatics Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Anti-rheumatics Market by Drug Class
9.3.2. Asia-Pacific Anti-rheumatics Market by Type
9.3.3. Asia-Pacific Anti-rheumatics Market by End User
9.3.4. Asia-Pacific Anti-rheumatics Market by Distribution Channel
9.3.5. Asia-Pacific Anti-rheumatics Market by Country
9.4. RoW
9.4.1. RoW Anti-rheumatics Market by Drug Class
9.4.2. RoW Anti-rheumatics Market by Type
9.4.3. RoW Anti-rheumatics Market by End User
9.4.4. RoW Anti-rheumatics Market by Distribution Channel
9.4.5. RoW Anti-rheumatics Market by Sub-region

10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Anti-rheumatics Market
10.2. Companies Profiled
10.2.1. Pfizer, Inc.
10.2.2. Johnson & Johnsons
10.2.3. Bristol-Myers Squibb Company
10.2.4. F. Hoffmann-La Roche Ltd.
10.2.5. Celegene Corporations
10.2.6. MedImmune, LLC
10.2.7. Takeda Pharmaceutical Company Ltd.
10.2.8. Biogen Inc.
10.2.9. Celltrion Inc.
10.2.10. Amgen Inc.

11. Appendix
11.1. Primary Research Findings and Questionnaire

For more information about this report visit https://www.researchandmarkets.com/r/8a5hbm

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/outlook-on-the-global-anti-rheumatics-industry-to-2025---key-drivers-restraints-and-opportunities-301073903.html

SOURCE Research and Markets